Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.
about
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virusVaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalkHepatitis B virus infection. Current concepts of chronicity and immunity.Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella.New hepatitis B vaccines.Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus.Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus.Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant.Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2.Hepatitis B viral antigenic structure: signature analysis by monoclonal radioimmunoassays.Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S proteinExpression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic miceProtection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigenLocalization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies.Inversely repeating integrated hepatitis B virus DNA and cellular flanking sequences in the human hepatoma-derived cell line huSP.Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines.Recombinant vaccinia viruses as new live vaccines.Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences.Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr.Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.Peptides as antigens. Importance of orientation.Expression and immunoreactivity of HCV/HBV epitopes.In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.Mise au point de nouveaux vaccins anti-h?patite B.
P2860
Q27485919-8E7D421C-A9AD-44A8-B234-8805DED072C0Q27486872-906286CE-0F3F-453B-9487-A3A74F951122Q33581104-A682D6C9-9E9C-4835-83DC-E79822A111E0Q33660809-8E48B401-EEEB-41CD-81B1-64E361D3B875Q33864236-BAE47472-7A35-4F4D-97F7-B1288A3B0BE5Q34490083-734407F0-591B-4F7F-9ADE-A1F418A96AE4Q34575501-AD8C61D2-172A-42DE-84BA-AD581DEDD118Q35141530-6E028323-E559-408C-9C11-67D3B9D454AAQ35679043-9FDF2DAB-7B41-4397-9515-957E7350279DQ36073500-88168155-4B4E-4FC8-91C5-0E46BF6B2996Q36213588-E25398A0-F1C3-49CF-A182-7CC4152ADE4CQ36266999-B15C8B7F-1DDF-4E5C-A2B7-4FA07FE62F52Q36267525-46DCFE51-FBEF-4097-B0C6-50453427CDD5Q36802452-539E665F-C0A0-4185-B0AC-EBD70928C503Q36869563-C87B276F-19DE-4C32-9328-1FB11ED6739DQ36869697-8875A99D-B35D-403B-BCC8-08C512335D79Q36906684-0F7F0233-6BB3-407A-BB77-233B9962AD10Q37672927-D04717D7-DB94-48C8-BCAE-ED875C3BA6E5Q37690884-EBF672C1-32FF-496C-B55F-5FB0F02C9C32Q40045663-BFDB0C8A-A16A-446F-B32B-44CE87DA8822Q40065187-945F9480-F0C1-48B5-97EE-8E5864E42EA2Q40081264-3CA67FF6-532F-49D1-AA71-45172EA4D7B5Q40131681-CA7ED4B2-FAEA-4D05-84EA-1C64A8883C94Q40140801-C0429CEB-B81D-4B39-843E-D7D8A73A0EFBQ40281152-9BD1C74F-7D22-4A03-99F3-749F3BA9D489Q42026698-4FE9FBF4-DD08-4AE4-B8E7-FAA41F32B064Q42997732-AFB577E2-6AE0-44AE-94FB-9D023FF71234Q45762700-417737CE-5B94-4216-882D-A582437C715BQ45797700-C8B4AB29-CB02-4338-B76A-93959FE504C5
P2860
Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemically synthesized peptide ...... fic antibodies in chimpanzees.
@en
Chemically synthesized peptide ...... fic antibodies in chimpanzees.
@nl
type
label
Chemically synthesized peptide ...... fic antibodies in chimpanzees.
@en
Chemically synthesized peptide ...... fic antibodies in chimpanzees.
@nl
prefLabel
Chemically synthesized peptide ...... fic antibodies in chimpanzees.
@en
Chemically synthesized peptide ...... fic antibodies in chimpanzees.
@nl
P2093
P2860
P356
P1476
Chemically synthesized peptide ...... fic antibodies in chimpanzees.
@en
P2093
G Dapolito
H Alexander
J G Sutcliffe
R A Lerner
R H Purcell
T M Shinnick
P2860
P304
P356
10.1073/PNAS.80.8.2365
P407
P577
1983-04-01T00:00:00Z